HRC Expertise
Each HRC has unique expertise to help you through your journey. However, all HRCs provide support to provide the necessary evidence to support your regulatory approvals.
Specialists in supporting HealthTech across the lifecycle
HRCs are experts in supporting innovators across the product lifecycle to ensure their products are developed safely and with patients at the centre.
While some innovations are funded by larger organisations developing them, the majority of new healthtech innovations come from small to medium sized enterprises (SMEs) or micro-organisations with fewer than 10 employees. In these instances, HRCs typically support the companies to secure the funding necessary to help them move their product along the lifecycle.
Evidence generation
To apply for regulatory approval to get innovations adopted and used across the NHS, innovators must provide evidence to demonstrate that they have created an innovation that meets a clinical need, that has been developed and trialled with patients, and that demonstrates value to the NHS. Click below to find out more about what types of evidence HRCs can support innovators with.
Many funders now require a full PPIE integration strategy in recognition of the value it provides. From co-design and acceptability testing, through to interpretation of results and advocating for adoption, HRCs can support meaningful PPIE activities to improve the quality of your devices throughout the development process, enhancing your chances of successful adoption and implementation. Find out more here.
Unmet need can be quantified via the PICO (Population, Intervention, Comparator, Outcome) framework and considers the need from the NHS's operational budget and the patient's lived experience. Validation involves a formal Clinical Gap Analysis and Care Pathway Mapping to prove the technology offers relative effectiveness over the current standard of care. PPIE activities can help validate problems that matter to patients and carers, what aspects of the current care pathway fail them, and what frustrations shape their overall experience. For high-impact innovations, the Innovative Devices Access Pathway (IDAP) or Early Value Assessment (EVA) provide formal Unmet Clinical Need Authorisation, which serves as the official green light for targeted evidence generation.
Clinical investigations specifically refer to studies involving medical devices. They are governed by the Medical Devices Regulations (UK MDR 2002) and, for those aiming for Northern Ireland or EU markets, the MDR (EU) 2017/745. They focus on the physical, mechanical, or software-driven performance of a tool used for diagnosis, monitoring, or treatment. Recruitment is strictly validated through Patient and Public Involvement and Engagement (PPIE) to ensure investigation designs are inclusive and feasible for underserved populations, a legal expectation under the new transparency and diversity mandates.
Care pathways are aligned to medical conditions and describe a patient’s journey across an episode of healthcare. Care Pathway Analysis (CPA) maps the processes and method for modelling a care pathway in a healthcare system and is used to assess the impact of bringing a new innovation into the clinic, to understand how their product will fit in and potentially change the current pathway. CPA is an important part of the early evaluation process as it helps identify problems in current pathways and the optimal role and place of the new innovation, and the optimal patient population to use the innovation with.
This helps innovators to understand which characteristics of their device would be clinically feasible and acceptable by providing clarity on who the technology is for, what problem it solves, and why it matters. A clear business case shows how these benefits translate to cost savings or health improvements, and can be translated into measurable outcomes for clinical studies, such as time-to-diagnosis, correct referral rates, and clinician time saved. This important work can support regulatory applications, determine clinical outcome measures for a future trial, inform R & D strategies, demonstrate commercial viability and plausible routes to adoption.
Health economics is the study of how healthcare resources are allocated, how much interventions cost, and what value they deliver in terms of health outcomes. It helps compare different tests, treatments, and pathways to determine which options provide the best results for the resources invested. Early health economics studies are performed earlier in the development process with an aim to explore potential cost-effectiveness, steer investment decisions, and identify key aspects of the care pathway that drive value. A full economic evaluation will assess the value of a device in a real-world setting, supporting reimbursement, pricing and policy decisions. A comprehensive economic model is required for NICE evaluation.
Regulatory support
There are many different routes to regulatory approval depending on the type of innovation, and where the innovation will be used. HRCs are experts in guiding innovators to ensure they get the right regulatory approvals to enable them to get their innovation to market and to patients.
- Regulatory classifications
In the UK, healthtech products are classified by the MHRA under the UK MDR 2002 (as amended) based on a tiered, risk-based system that determines the level of regulatory scrutiny required. For software-as-a-medical-device (SaMD) and AI, recent 2026 updates are shifting most diagnostic or treatment-influencing tools out of Class I and into Class IIa or higher, requiring mandatory assessment by a UK Approved Body. For software-as-a-medical-device (SaMD) and AI, recent 2026 updates are shifting most diagnostic or treatment-influencing tools out of Class I and into Class IIa or higher, requiring mandatory assessment by a UK Approved Body.
- CE and UKCA regulatory markings
While the UKCA mark remains a valid and available domestic route, the MHRA proposes that devices compliant with the EU MDR and IVDR can be placed on the market without a separate UK certification, a move intended to protect patient access to the 90% of healthtech products currently imported from the EU. Under existing transitional arrangements, CE-marked devices remain legally accepted until at least 2028 or 2030 (depending on the device class), but the new 2026 proposals aim to remove these sunset dates entirely, repositioning the UKCA as a specialized innovation route for first-in-market technologies like AI-as-a-medical-device (AIaMD).
NICE evaluates and develops guidance for healthtech to improve the uptake of devices and technologies in the NHS, particularly those that deliver treatment (e.g., surgical implants), give greater independence to patients, or detect and/or monitor medical conditions. Their guidance is based on the stage that an innovation is currently at and NICE often group healthtech products that have a similar use, or address a similar need. They can make a recommendation for the use of the approved innovation will guidance on how it should be used, not used or used only in specific conditions (such as managed access periods, or for research). They also provide recommendations on using certain innovations over other similar technologies in use in the NHS, and what to consider when choosing between these technologies.
The Medicines and Healthcare products Regulatory Agency (MHRA) acts as the UK’s executive "gatekeeper" and safety supervisor for all medicines, medical devices, and blood components. Its primary mandate is to protect public health by ensuring that healthcare products meet rigorous standards of safety, quality, and clinical performance before they reach the market and throughout their entire lifecycle. They authorise clinical trials and investigations, certify high-risk devices, and manage the Yellow Card scheme for reporting adverse incidents and accelerate access to Software-as-a-Medical-Device (SaMD) and AI-as-a-Medical-Device (AIaMD).
Find the HRC that is right for you
To find out more about each of our HealthTech Research Centres, you can read more about them in the profiles below.
To narrow down your search, you can filter by clinical theme or use the free text box to search for keywords.
Filter by clinical theme
Or type your search term below
Accelerated surgical care
The HRC in Accelerated surgical care are working with medical device, diagnostic and digital health technology companies to develop new innovative medical technologies, generate the evidence to demonstrate financial value (health economics) or improve operational efficiency in the NHS (real-world evidence generation).
They aim to drive HealthTech innovation for patients and healthcare systems to deliver socio-economic benefit through quicker diagnosis and treatment of surgical conditions with safe, early recovery in the community.
The HRC in Accelerated surgical care are working with medical device, diagnostic and digital health technology companies to develop new innovative medical technologies, generate the evidence to demonstrate financial value (health economics) or improve operational efficiency in the NHS (real-world evidence generation).
They aim to drive HealthTech innovation for patients and healthcare systems to deliver socio-economic benefit through quicker diagnosis and treatment of surgical conditions with safe, early recovery in the community. Accelerated surgical care Accelerated Surgical Care
Accelerated Surgical Care is a specialised, multidisciplinary approach that focuses on speeding the time to surgery following a diagnosis. Reducing the duration between these key health milestones can have a positive impact on overall health outcomes. Related to this is Enhanced Recovery After Surgery (ERAS) which speeds up the post-surgery recovery process (e.g., through early mobilisation).
Expertise through unrivalled access to world-leading medical diagnostics expertise and extensive clinical networks.
State-of-the-art facilities by facilitating access to specialist equipment relevant to distinct specialisms, for example, simulation suites.
Advice on the suitability of new technologies and the evidence required to support their commercial uptake.
Collaboration by brokering collaborations between industry and clinical practice to test new technologies in community settings.
Patient and public involvement – public contributors are at the centre of the HRC, helping to steer and govern our work to ensure it is relevant to patients and carers.
Study delivery – in-house delivery of clinical trials, health economics, health informatics, multidisciplinary pathology capabilities, and generation of high quality evidence. Advice and collaboration.
Clinical themes
Early diagnosis and personalised care
Minimally invasive therapies and digital technologies
Assistive healing and rehabilitation
Methodological themes
Timely clinical and economic evaluation
Sustainability and NHS Net Carbon Zero
Surgical care observatory
Expertise
Assets
SurgTech (annual international conference)
National HealthTech Series Industry
Engagement Events/Roadshows
SUSTAIN - high-fidelity simulated operating theatre providing a testbed for circular innovations, enabling industry and academia to evaluate new technologies, improve decision-making, and train healthcare teams in sustainable practices
HRC Surgical HRC Surgical LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Accelerated surgical careLevel 7 Clinical Sciences BuildingSt James's University HospitalBeckett StreetLeedsWest YorkshireLS9 7TF Hosted by Leeds Teaching Hospitals NHS Foundation Trust in partnership with Leeds University 3 - 8 Innovators wishing to access support from Accelerated Surgical Care should complete the Technology Assessment Form on the HRC website. Note that they can only provide support to innovators with clinical relevance, so innovators are advised to check this against the HRC theme details on their website. ASC_HistoSonics System
|
|
|
|
|
|
Brain health
The HRC in Brain health uses cutting edge technologies including brain scanning, blood sampling, and computerised testing and technology to solve major challenges in the field of brain health and dementia research in diagnosis, care, and treatment. Their aims are to expedite the development and integration of emerging technologies to create a more intelligent and accessible way of diagnosing dementia in the early stages of the condition, and focus on swiftly delivering benefits to patients to reduce the impact of dementia on society.
The HRC in Brain health uses cutting edge technologies including brain scanning, blood sampling, and computerised testing and technology to solve major challenges in the field of brain health and dementia research in diagnosis, care, and treatment. Their aims are to expedite the development and integration of emerging technologies to create a more intelligent and accessible way of diagnosing dementia in the early stages of the condition, and focus on swiftly delivering benefits to patients to reduce the impact of dementia on society. Brain health In this context, brain health refers to people at risk of, or in the very first stages of cognitive impairment, and the early diagnosis of Alzheimer’s disease and other neurodegenerative diseases in people with Mild Cognitive Impairment.
To expedite the development and integration of emerging technologies in healthcare, with a focus on swiftly delivering benefits to patients.
Support new technologies to reduce the impact of dementia on society.
Early accurate diagnosis of dementia and cognitive disorders.
Interventions to foster enablement and support for people with dementia at home and in care homes.
Evaluation of technologies and technology-supported clinical trials using our online PROTECT-UK registry.
Clinical themes
Early diagnosis of cognitive disorders
Support for people with dementia
Technology supported clinical trials
Methodological themes
Expertise
Patient and public involvement and engagement (PPIE) and Research inclusion
Entrepreneurial skills
Evidence generation
Clinical research delivery
Workforce development
Assets
PROTECT Study (longitudinal cohort)
King's MedTech Accelerator Programme
Entrepreneurial skills training
In-residence support
CARE Network study (longitudinal cohort across ethnic and faith groups)
HRC BrainHealth HRC BrainHealth LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Brain healthSouth London and Maudsley NHS Foundation Trust Maudsley HospitalDenmark HillLondonSE5 8AZ Hosted by South London and Maudsley NHS Foundation Trust, the team work in collaboration with the Institute of Psychiatry, Psychology and Neuroscience at King's College London and the University of Exeter. 1 - 9 Innovators can contact this HRC through This email address is being protected from spambots. You need JavaScript enabled to view it.. From this stage, they will be contacted by the HRC to discuss alignment to their brain health scope and mutual benefits. Those who meet the requirements are asked to complete a Confidential Disclosure Agreement. Once that has been received, innovators are asked to submit a synopsis of their project or ideal collaboration via an MS form.
|
|
|
Brain injury
The HRC in Brain injury supports researchers and innovators to identify unmet needs, evaluate the effectiveness of their technology and implement these solutions to improve the quality of life of those affected by brain injury. Acute care, monitoring of neurological disorders, physical and psychological rehabilitation techniques, and regenerative medicines can all reduce long-term injury and improve long term health. The team works closely with its network of national partners, to support research at every stage of development. They work with patients, carers, and families, to ensure that innovation is meeting a need within the community and making a real difference to those who need it most.
The HRC in Brain injury supports researchers and innovators to identify unmet needs, evaluate the effectiveness of their technology and implement these solutions to improve the quality of life of those affected by brain injury. Acute care, monitoring of neurological disorders, physical and psychological rehabilitation techniques, and regenerative medicines can all reduce long-term injury and improve long term health. The team works closely with its network of national partners, to support research at every stage of development. They work with patients, carers, and families, to ensure that innovation is meeting a need within the community and making a real difference to those who need it most. Brain injury Conditions affecting the brain and spine affect large numbers of people and often have a significant impact on their quality of life. Brain injuries can be overwhelming for people, their families, and society. Brain development at the beginning of life (e.g., prematurity, acquired brain injury), and brain degeneration at the end of life (e.g., frailty, co-morbidities) are both areas where specialised care is required. Long-term acquired brain injuries (or ABIs) are also common in people who have had sports concussions, falls or head injuries as a young child, and the homeless and prison population frequently report a history of brain injury.
Reduce Acquired Brain Injury (ABI) by focusing on the three forms of injury prevention: primary prevention – increase the knowledge of the causes of ABI and educate communities working with at-risk groups on how to prevent ABI; secondary prevention – improve screening and diagnosis of ABI to increase early intervention and reduce long-term brain injury; and tertiary prevention – improve the ability to identify individuals experiencing ABI in the community and improve access to care services for those with brain injury.
Improve acute care in hospitals and monitoring brain activity following this, to improve recovery pathways for those with brain injury. In particular: improving imaging used for diagnosing mild and severe TBI (traumatic brain injury), including using AI to analyse CT scans in emergency departments; neuroprotective innovations to reduce secondary brain injury acquired during recovery; multimodality monitoring of brain injury, using biological markers to track recovery; supporting surgical innovations to improve technologies used during neurosurgery; and reporting neurological outcomes when assessing other areas to raise awareness across services to improve brain care.
Use new neuro-imaging, innovative approaches for assessing intracranial dynamics, and the application of molecular testing of brain tumours. In particular: the evaluation of PET markers and the clinical application of el imaging approaches including MRI scan data for tumour treatment planning, leading to safe and improved resection of tumours; molecular diagnostics, including whole genome analysis of tumour tissue for improved diagnostic classification, and analysis of cell-free DNA for early diagnosis and monitoring; improving non-invasive intracranial pressure monitoring by improving models for estimation and applying machine learning techniques to monitor this; and evaluation of dynamic imaging to evaluate CSF disorders, including PC-MRI application in normal pressure hydrocephalus, and determination of physiological brain compliance.
Support bespoke rehabilitation interventions, targeted cognitive assessments, and frameworks for systematic evaluation; utilisation of human cellular models of disease; evaluation of neuroprotective agents, surgical approaches, and targeted therapies.
Understanding brain health at the beginning and end of life. For neonatal care, this includes: improving pathways and evaluation of the importance of baby-parent contact; new technology in neonatal brain imaging, including the development of the fUSiON project cot-side functional brain imaging device for intensive care; expansion of the genomic screening for the diagnosis of rare childhood diseases. For elderly medicine, this includes: improving recognition, treatment and ongoing care of under-diagnosed, treatable conditions in the elderly (such as cervical myelopathy and idiopathic normal pressure hydrocephalus); reducing the need for elderly people to visit hospital by developing community alternatives to delivering neurological rehabilitation (such as telerehabilitation, providing these to homes and local care facilities).
Clinical themes
Prevention and education
Acute care monitoring
Restoration and rehabilitation
Diagnostics
Life course
Methodological themes
Expertise
Digital, AI and data
Assets
Neurosurgery registries (secure data environment and hosting for registry information
HRC BrainInjury HRC BrainInjury LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Brain InjuryAcademic Neurosurgery, Box 167Cambridge Biomedical CampusCambridgeCB2 0QQ Hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with University of Cambridge 1 - 9 Innovators who would like to access support from this HRC should contact This email address is being protected from spambots. You need JavaScript enabled to view it. and register their interest. A member of the HRC will send an initial engagement form and/or contact you to discuss your innovation and assess if they have the appropriate expertise to support the innovation. Should agreement be reached during this conversation, the HRC will work with the innovator to produce a comprehensive 360 Assessment of the technology and its value. As part of this, the centre will provide appropriate next steps for innovations development and implementation. Treating reversible dementia
|
|
|
|
|
Cardiovascular and respiratory medicine
The HRC in Cardiovascular and respiratory medicine drives innovation and supports the development of HealthTech solutions to address the unmet needs outlined in the NHS Long Term Plan. The team aims to catalyse innovation in HealthTech for the diagnosis and management of cardiovascular and respiratory diseases through cutting-edge technologies and digitally enabled care. This empowers patients and their caregivers to effectively manage cardiovascular health and conditions. They bring together their vast clinical expertise to support researchers and industry throughout the UK to enhance clinical service quality and reduce variation in patient care.
The HRC in Cardiovascular and respiratory medicine drives innovation and supports the development of HealthTech solutions to address the unmet needs outlined in the NHS Long Term Plan. The team aims to catalyse innovation in HealthTech for the diagnosis and management of cardiovascular and respiratory diseases through cutting-edge technologies and digitally enabled care. This empowers patients and their caregivers to effectively manage cardiovascular health and conditions. They bring together their vast clinical expertise to support researchers and industry throughout the UK to enhance clinical service quality and reduce variation in patient care. Cardiovascular and respiratory medicine Cardiovascular disease (CVD) and respiratory medicine is a combined medical specialty that integrates cardiology and pulmonology to treat conditions of the heart and circulatory systems, and the lungs and respiratory systems. It focuses on diagnosing, treating, and managing diseases of the heart, blood vessels, and lungs, and includes conditions like coronary heart disease and heart failure, high blood pressure, asthma, and chronic obstructive pulmonary disease (COPD).
Advanced physiological biomarkers for home monitoring in chronic obstructive pulmonary disease (COPD).
AI-based CT lung vasculature imaging for disease prognostication and progression in pulmonary thromboembolism / pulmonary hypertension subclasses.
App-based technologies and implantable pulmonary artery pressure monitors for home exercise testing, activity monitoring and drug titration in patients with pulmonary hypertension.
Physiology-based technical engineering in devices to improve long-term outcome in sleep-disordered breathing and chronic respiratory failure.
Leverage local expertise for the technology evaluation of novel digital health solutions in collaboration with clinicians and methodologists.
Promote the creation of well-curated clinical databases, to accelerate evaluation of novel technologies.
Reduce inequalities and involve the public, patients and carers ensuring our research has clinical impact and empower patients and their caregivers to effectively manage cardiovascular health and conditions.
Catalyse innovation in HealthTech for the diagnosis and management of cardiovascular and respiratory diseases through cutting-edge technologies and digitally enabled care.
Understand the needs of those affected by children's heart disease and develop healthtech that supports the broader wellbeing of young people, and expose the cost of caring for children with heart disease.
Health technology evaluations - Supporting, piloting or co-developing novel HealthTech in key areas of unmet need.
Access to key opinion leaders, researchers and clinical and scientific experts in areas relating to cardiovascular and respiratory medicine.
Optimise the pipeline by coordinating resources while building capacity through short practical courses in health technology assessment, trial statistics, and health economics for NHS professionals at all career stages.
Access to key opinion leaders, researchers and clinical and scientific experts in areas relating to cardiovascular and respiratory medicine.
Clinical themes
Advanced respiratory monitoring, imaging and treatment
Cardiovascular disease in adults
Cardiovascular interventions
Heart disease in children
Methodological themes
Medical device evaluation (adaptable to all TRLs)
Process evaluation
Evidence generation for developers, adopters, decision makers
Health technology assessment
Human factors, heuristics and usability
Mixed qualitative and quantitative methods
Co-design of devices and adoption
Pre-implementation support
Contextual analysis
"Living Lab" services (human factors techniques)
Expertise
Health economics and Health Tech Assessment (HTA)
Human factors analysis and usabilty assessment (instrumented and heuristic)
Codesign
Unmet needs gathering and assessment through patient and public involvement
Cardiology
Respiratory medicine
Regulatory advice
Vascular surgery
Biomedical engineering
Quality management systems
Clinical trials, first in man
System design
Technology adoption
Post-market surveillance and real-world evidence
Assets
Med Accelerator program targeted at early-stage ideas, providing training and support for collaborative grant applications
Venture Builder program that assists semi-developed products to achieve CE marking through the King's Technology Evaluation Centre (KiTEC)
Manfacture of Active Implants & Surgical Instruments (MAISI)
London Institute for Healthcare Engineering (LIHE)
SIE Ventures
Heart, Lung & Critical Care (HLCC) clinical group
CARDIAC MRI
Access to ethically approved research databases and tissue banks
HRC CardioResp HRC CardioResp LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Cardiovascular and respiratory medicineLondon Institute for Healthcare Engineering 100 Lambeth Palace Road London SE1 7AR Hosted by Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London 1 - 9 Innovators approach the HRC through a Collaboration Request Form via the HRC website. This elicits information about the company, the support required and funding. After an initial review, and requests that align with their remit are invited to a meeting to discuss further.
|
|
|
|
|
Community healthcare
The HRC in Community healthcare works to improve healthcare outside of hospitals, in the community and interface care, by developing, evaluating and implementing innovative health technologies. Its aim is to improve patient outcomes and reduce pressure on hospital services. The centre operates across community healthcare to identify the clinical needs of clinical staff, patients and carers for technologies that could improve care delivery, life quality and access to care. It works to support the development of appropriate technologies where unmet needs are identified, and robustly evaluates new and existing technologies before deployment, to ensure that they are safe to use and that users understand their strengths and limitations.
The HRC in Community healthcare works to improve healthcare outside of hospitals, in the community and interface care, by developing, evaluating and implementing innovative health technologies. Its aim is to improve patient outcomes and reduce pressure on hospital services. The centre operates across community healthcare to identify the clinical needs of clinical staff, patients and carers for technologies that could improve care delivery, life quality and access to care. It works to support the development of appropriate technologies where unmet needs are identified, and robustly evaluates new and existing technologies before deployment, to ensure that they are safe to use and that users understand their strengths and limitations. Community healthcare Community healthcare is an umbrella term to represent a range of medical, nursing, and rehabilitative services that are provided outside of hospitals, usually in patients' homes, clinics, schools, or community hubs. These services aim to keep people healthy, manage long-term conditions, and support independent living for people of all ages and with a wide range of clinical and support needs.
Expert clinical input from day one.
Regulatory and commercial guidance.
Access to diverse test beds across primary care, care homes, and community settings.
Support with study design and funding applications.
Efficient evaluation through innovative platform studies.
Implementation expertise to drive NHS adoption.
Reducing burden through smart diagnostics and monitoring.
Reimagining community-based care for children.
Revolutionising early detection and diagnosis.
Enabling new models of virtual and home-based care.
Enhancing holistic care for underserved populations.
Clinical themes
Respiratory
Infections and acute paediatrics
Cancer diagnosis
Care homes and care in the home
Mental health and equitable access to care
Methodological themes
HealthTech evaluation methodology
Need-led device development and regulatory
Digital healthtech
Expertise
Assets
HRC Community HRC Community LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Community healthcareNuffield Department of Primary Care Health SciencesRadcliffe Primary Care BuildingRadcliffe Observatory QuarterWoodstock RoadOxfordOX2 6GG Hosted by Oxford Health NHS Foundation Trust in partnership with the University of Oxford (Nuffield Department of Primary Care Health Sciences) 1 - 9 Innovators can register interest via an Industry Contact Form on the HRC website, which gathers information about the organisation, the readiness of their technology and its intended uses. Innovations that are within their remit and of interest are followed up with a meeting to discuss in more detail. Suspected CANcer (SCAN) Diagnostic
|
|
|
|
|
|
|
|
Devices, digital and robotics
The HRC in Devices, digital and robotics plays a key role in identifying unmet clinical needs and generating evidence to support the regulatory approval and adoption of healthcare technologies. The team provides a national service to support the translation of medical devices, digitally delivered health and robotics systems safely and effectively into routine care in the NHS and follow-on social care. They collaborates with industry, academia and healthcare professionals developing technologies across technology readiness levels (TRLs) to improve patient outcomes and experience and improve healthcare efficiency.
The HRC in Devices, digital and robotics plays a key role in identifying unmet clinical needs and generating evidence to support the regulatory approval and adoption of healthcare technologies. The team provides a national service to support the translation of medical devices, digitally delivered health and robotics systems safely and effectively into routine care in the NHS and follow-on social care. They collaborates with industry, academia and healthcare professionals developing technologies across technology readiness levels (TRLs) to improve patient outcomes and experience and improve healthcare efficiency. Devices, digital and robotics Medical devices include HealthTech products intended for diagnosing, preventing, monitoring, treating, or alleviating disease and injury that can range in complexity from walking sticks to dialysis machines. Data driven and digitally delivered care refers to the collection, storage, analysis and sharing of patient information and medical metrics such as electronic patient records, wearable data and sensors and telemedicine. Robotics use physical machines and automated systems to perform specific medical or logistical tasks, often with high precision. Digital technologies and robotics can include the integration of artificial intelligence (AI).
Clinical expert reviews: we can provide innovators with expert insight into the unmet clinical need, design and functionality requirements of early-stage health technologies through our clinical expert review process.
Grant application support: we can help innovators to identify suitable funding opportunities and support grant writing by providing insight and feedback on applications. Working in collaboration with innovators, we can develop work packages to generate evidence to increase technology readiness.
Human factors and usability testing: we can conduct iterative usability tests across the product lifecycle in realistic environments with patient simulators (working human models) within the MD-TEC facility, in compliance with international standards.
First-in-human clinical investigations: we can support the preparation of study documentation and submission for regulatory approval to assess essential safety and performance.
Patient and public involvement and engagement (PPIE): our dedicated PPIE Manager offers enabling support, advice and guidance to help innovators engage effectively with members of the public, ensuring the patient voice is heard throughout technology development.
Health economics: we develop value proposition calculations, build optimal pricing strategies and conduct model-based economic analyses with support from our dedicated health economist.
Regulatory support: we understand the appropriate regulations with consideration of evidence generation requirements needed for regulatory approval, where required.
Clinical themes
Data and digital
Medical devices
Robotics and autonomous systems
Methodological themes
Human factors and usability testing
Health economics and value proposition
Regulation
Expertise
Human factors and usability testing
Health economics
Patient and public involvement and engagement (PPIE)
Navigating the regulatory pathway
Assessment of unmet clinical need
Assets
The NIHR HRC-DDR is co-located with the Medical Devices Testing and Evaluation Centre (MD-TEC). MD-TEC is a dedicated, state-of-the-art medical device and technology usability testing facility that allows the simulation of complex clinical scenarios for product testing
UHB host a number of NIHR and non-NIHR funded research infrastructures providing opportunities for collaboration. Examples include the NIHR Birmingham Clinical Research Facility, supporting the delivery of clinical investigations and the West Midlands Secure Data Environment (WM-SDE), a resource to support healthcare data needs of technology projects
HRC DDR HRC DDR LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Devices, digital and roboticsInstitute of Translational MedicineHeritage BuildingMindelsohn WayB15 2TH Hosted by University Hospitals Birmingham NHS Foundation Trust in partnership with the University of Birmingham 1 - 7 This HRC holds calls for collaborative project proposals regularly throughout the year. Each call is launched with a webinar and comprehensive guidance on how to submit a proposal application. Once the call has closed, each application is reviewed to assess feasibility and alignment to the support they can provide. Innovators who progress through initial review are invited to a presentation meeting for a collaborative discussion with the team about their proposal including aims of the project, clinical need, technical innovation and public acceptability and accessibility. The review team then decide on which proposals they are able to progress. Innovators who are offered a collaboration are invited to a kick-off meeting to establish work packages, objectives and timelines.
|
|
|
|
|
|
Diagnostic and technology evaluation
The HRC in Diagnostic and technology evaluation applies innovative clinical research methods to efficiently evaluate diagnostic technologies. The centre examines whether new diagnostics are clinically useful, cost-effective and beneficial to the public. Through supporting funding applications, working in partnership on projects, and delivering training, they help diagnostic innovators thrive and build their evidence. Since 2013 they have worked with over 280 companies including over 180 small and medium-sized enterprises. They have helped innovators obtain over £25 million in external funding and delivered commercially funded projects. They support the development of diagnostic technologies from their invention to their adoption. They specialise in three clinical themes: Ageing and multiple long-term conditions, infection, and precision medicine and rare diseases. By supporting better diagnostics, they hope to improve people’s health and care.
The HRC in Diagnostic and technology evaluation applies innovative clinical research methods to efficiently evaluate diagnostic technologies. The centre examines whether new diagnostics are clinically useful, cost-effective and beneficial to the public. Through supporting funding applications, working in partnership on projects, and delivering training, they help diagnostic innovators thrive and build their evidence. Since 2013 they have worked with over 280 companies including over 180 small and medium-sized enterprises. They have helped innovators obtain over £25 million in external funding and delivered commercially funded projects. They support the development of diagnostic technologies from their invention to their adoption. They specialise in three clinical themes: Ageing and multiple long-term conditions, infection,â¯and precision medicine and rare diseases.â¯By supporting better diagnostics, they hope to improve peopleâs health and care. Diagnostic and technology evaluation Diagnostic and technology evaluation refers to the scientifically rigorous examination of tests and devices related to imaging, artificial intelligence, and digital healthcare that are used for diagnosing medical conditions. The centre embeds patient and public involvement and engagement (PPIE) into their evaluations which include examining clinical and cost effectiveness. This ensures only high-quality tools that have healthcare system and patient benefits are adopted into the NHS.
Ageing and multiple long-term conditions: evaluating diagnostics that are fit for the needs of older patients, building on the North East’s international reputation for research excellence in ageing.
Infection: expanding the centre's proficiency in evaluating diagnostics for infectious diseases, including respiratory infections and urinary tract infections alongside devices that identify the most appropriate treatments to combat antimicrobial resistance.
Precision medicine and rare diseases: evaluating tests that identify patients who will respond to specific treatments, strengthening the North East's world leading expertise in this area.
Evidence generation including care pathway analysis; identifying value propositions; design and analysis of analytical performance and diagnostic accuracy studies; health economics and PPIE.
Business support including colloboration on funding applications; training and project management.
Assessment of unmet clinical need.
Clinical themes
Ageing and multiple long-term conditions
Infection
Precision medicine and rare disease
Methodological themes
Qualitative methods including: target product profile development and unmet needs; clinical landscaping; expert elicitation; systematic reviews; regulatory support
Quantitative methods including: analytical performance; diagnostic accuracy; early health economics; health economics
Mixed methods including: care pathway analysis; value propositions; PPIE; clinical study design; usability testing; post-market surveillance
Expertise
Evidence generation including care pathway analysis; identifying value propositions; design and analysis of analytical performance and diagnostic accuracy studies, health economics and Public and Patient Involvement and Engagement (PPIE)
Business support including colloboration on funding applications; training and project management
Assets
They deliver regular training courses around evidence generation for diagnostics development
They have developed several diagnostic web applications
They can support PPIE within projects through facilitating meetings with their Insight Panel for Patients, Public and Carers.
HRC Diagnostics HRC Diagnostics LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Diagnostic and Technology EvaluationNewcastle UniversityNewcastle Upon TyneNE2 4HH Hosted by the Newcastle upon Tyne Hospitals NHS Foundation Trust in partnership with Newcastle University 1 - 9 (typically 3 - 7) Innovators wishing to receive support from this HRC should make an initial enquiry through their Contact Form on their website. This will ask for information about the innovator, the innovation and if any evidence, regulatory approvals, or funding have already been achieved. A triage team consisting of HRC staff, clinicians and lab staff, and methodologists, will review the information received and assess HRC expertise, resource and routes to funding. The HRC aim to make a decision based on all available information within 3 weeks. Rapid Diagnostics for Stroke
|
|
|
|
|
|
Emergency and acute care
The HRC in Emergency and acute care aims to transform emergency and acute care by developing and deploying new technologies for the detection, diagnosis and treatment of disease, and embedding these technologies into everyday clinical practice. The team work with patients and innovators to co-develop technologies and generate the evidence required to achieve adoption in the health and care system at pace and scale. This ensures new HealthTech solutions are sustainable, benefit all communities, and support fair and equal access to healthcare, helping to improve health and wellbeing for all.
The HRC in Emergency and acute care aims to transform emergency and acute care by developing and deploying new technologies for the detection, diagnosis and treatment of disease, and embedding these technologies into everyday clinical practice. The team work with patients and innovators to co-develop technologies and generate the evidence required to achieve adoption in the health and care system at pace and scale. This ensures new HealthTech solutions are sustainable, benefit all communities, and support fair and equal access to healthcare, helping to improve health and wellbeing for all. Emergency and acute care Acute care is a branch of secondary health care (hospital settings) where patients receive active, short-term treatment for a severe injury, illness, urgent medical conditions, or recovery from surgery. This HRC also includes the interface between primary and community care, such as GP surgeries and care homes, ambulatory services and accident and emergency departments, which together form the link between primary and secondary care.
Providing expert advice, linking with healthcare professionals, setting up ‘Key Opinion Leader’ panels.
Understanding the scale of the healthcare problem a technology aims to address in terms of health and the population.
Concept validation and identifying the ‘use case’ and care pathway that the novel technology will fit into.
Regulatory guidance and strategy development.
Establishment of project teams including clinical, patient, academic and regulatory partners as appropriate.
Grant writing support, being a partner on a collaborative application.
Project oversight and direction.
Health economics – what is the benefit to patients, healthcare, and the economy?
Patient and public involvement and engagement (PPIE).
Design, set up and running of clinical studies to establish diagnostic accuracy, clinical validation and clinical utility.
Rapid set up and delivery of diagnostic accuracy studies. You can find out more in our VALIDATE case study.
Identifying barriers to adoption and looking at implementation science and behaviour change.
Signposting within the NHS, Greater Manchester research and innovation ecosystem, local and national NIHR infrastructure and HRC Network.
Rapid set up and delivery of diagnostic accuracy studies. You can find out more in our VALIDATE case study.
Clinical themes
Community, primary and the community-secondary care interface
Secondary care
Methodological themes
Understanding the problem
Evaluating the solution
Expertise
Care pathway analysis
In-vitro diagnostics
Wearables
Health economics
Use case identification
Trial design
Budget impact analysis
Trial based cost effectiveness
Evaluation using observational designs
Electronic health records
Quasi experimental designs
Understanding the value proposition
Model based cost effectiveness analysis
Stated preference methods (discrete choice experiments)
Artificial intelligence and machine learning
Assets
Please review the resource page on our website with training sessions and useful resources: Resources - Manchester HRC NIHR
HRC Emergency HRC Emergency LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. HRC in Emergency and acute careCityLabs 1.0 Nelson Street Manchester M13 9NQ Hosted by Manchester University NHS Foundaiton Trust, in partnership with The University of Manchester 3 - 8 Innovators can register their interest with the HRC by completing an Enquiry Form or by contacting them by email. If your request is within the remit, innovators will be asked to complete an Innovation Assessment Form. This is reviewed by a prioritisation panel, which provides a feedback report. The project plan is then developed if the company wants to move forward with the recommendations. Our impact
|
|
|
|
In-vitro diagnostics
The HRC in In-vitro diagnostics supports innovators to accelerate their market adoption, evaluate and generate evidence, develop research methods, and support diagnostic test development. The centre has access to extensive clinical networks, academic collaborators and advanced assessment methodologies, uniquely positioned to support innovators, from individuals to small and medium-sized enterprises and large multinational organisations.
The HRC in In-vitro diagnostics supports innovators to accelerate their market adoption, evaluate and generate evidence, develop research methods, and support diagnostic test development. The centre has access to extensive clinical networks, academic collaborators and advanced assessment methodologies, uniquely positioned to support innovators, from individuals to small and medium-sized enterprises and large multinational organisations. In-vitro diagnostics In-vitro ("in glass") diagnostics refers to the testing of samples (e.g. blood, urine, tissue) outside of the body (usually in petri dishes or test tubes) to detect or monitor diseases, or for screening. This HRC focuses on innovations for cancer, infectious and respiratory diseases, in a range of different settings from hospital to community.
Clinical translational research: supporting the rapid clinical evaluation of medical technologies through the design and delivery of robust clinical trials, providing access to patients and samples. The approach includes the development of biomarker-associated interventions and randomised controlled trials.
Biomarker translation: the Biomarker Toolkit enables critical appraisal of biomarkers across four key categories: rationale, clinical validity, clinical utility, and analytical validity. By applying this toolkit, researchers can identify gaps in their studies, guide the development of biomarkers toward clinical implementation, and determine which candidates show the most promise for clinical use.
Clinical pathways analysis: engage with key stakeholders and develop a thorough map of the current clinical pathway, bottlenecks, and opportunities for the integration of an innovation. From this we can identify scenarios of use and potential barriers to the adoption of the innovation.
Decision analysis: studies focus on understanding the impact that a healthcare innovation could have on clinical decision-making practices, utilising a range of methods to analyse decision-making, to gain insight on the degree to which an innovation can support clinicians' decision-making and to identify clinical decision implications.
Understanding barriers to adoption: insight into barriers to adoption or implementation can be used at different stages of the design cycle to enhance product design, development, and integration. Engage with key stakeholders within specific clinical pathways and develop a map of the clinical pathway, bottlenecks, and opportunities for the integration of an innovation, and identify scenarios of use and potential barriers to the adoption.
Health economics and market analysis: evaluations focus on identifying the optimal placement for a new technology within existing care pathways and describe the health and cost effectiveness of introducing a new device.
Patient and Public Involvement and Engagement (PPIE): support innovators looking to produce solutions for any care setting or pathway. Doing so recognises the value of bringing together people of all ages and backgrounds with experience of the health and care system. Patient and public engagement brings patients, service users, carers, and community members together from a range of groups to inform our studies.
Clinical themes
Cancer
Infectious and respiratory diseases
Critical care
Primary and social care
Methodological themes
Methodology
Real-world evidence generation
Human factors evaluation
Health Economics Evaluation
Expertise
Needs-focused, 360 degrees roadmapping
Public and patient involvement and engagement (PPIE)
Adoption
Scaling up technology readiness
Regulatory readiness support
Human factors laboratory validation
Assets
HRC InVitro HRC InVitro LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in In-vitro diagnosticsImperial College London St. Mary's HospitalPraed StreetGreater LondonW2 1NY Hosted by Imperial College Healthcare NHS Foundation Trust in partnership with Imperial College London 2 - 9 Innovators can register their interest in working with this HRC by completing an Enquiry Form through their website. All inquiries are triaged to determine alignment and viability. If deemed appropriate, a formal scoping process begins. Cancer breath test
|
|
|
|
|
Long-term conditions (Devices for Dignity)
The HRC in Long-term conditions (Devices for Dignity) acts as a catalyst for the development of innovative medical devices, healthcare technologies and technology-dependent interventions that help people to live well for longer. Working alongside patients and carers with lived experience of long-term health conditions, the team accelerates equitable access to HealthTech that has evidenced benefits for people with inter-related conditions, supporting them to live their lives well for longer with impacts on dignity, independence and life quality. Their commitment is to bridge the gap between pioneering research and practical application, ensuring that beneficial healthcare products and transformative interventions reach patients who need them most, improving quality of life and advancing healthcare worldwide
The HRC in Long-term conditions (Devices for Dignity) acts as a catalyst for the development of innovative medical devices, healthcare technologies and technology-dependent interventions that help people to live well for longer. Working alongside patients and carers with lived experience of long-term health conditions, the team accelerates equitable access to HealthTech that has evidenced benefits for people with inter-related conditions, supporting them to live their lives well for longer with impacts on dignity, independence and life quality. Their commitment is to bridge the gap between pioneering research and practical application, ensuring that beneficial healthcare products and transformative interventions reach patients who need them most, improving quality of life and advancing healthcare worldwide Long-term conditions (Devices for Dignity) Long-term conditions refer to chronic diseases that are frequently incurable, often degenerative, and require consistent monitoring, treatment and management. Their prevalence increases with age, and in many cases, people experience co-morbidities, including mental health conditions which are commonly experiened alongside long-term physical conditions.
Project oversight and direction.
Establishment of project teams including clinical, patient, academic and design partners as required.
Concept validation and scoping of clinical 'fit'.
Clinical evidence planning, from proof of concept to large scale trials.
Regulatory guidance and strategy development.
Patient and public involvement and engagement.
Dissemination planning.
Support with funding applications.
Market analysis including proof of market.
Exploitation strategy development.
Adoption and implementation planning.
Relationship building and signposting within the NHS, health and social care, and technology sectors.
Clinical themes
Diabetes
Long-term neurological conditions
Women's health
Kidney care
Mental health and wellbeing
Rehabilitation, assistance and restorative technologies
Methodological themes
Methodological innovation
Pathways to implementation and impact
Expertise
Agile project management
Deep product lifecycle knowledge used to progress projects through challenges and blockers.
Care pathway knowledge and care pathway analysis
AI and data
Assets
Health economics partnership
The Healthcare Scientist Innovation Fellowship Programme (by approval only)
HRC Long-term HRC Long-term LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Long-term conditions (Devices 4 dignity) Sheffield Teaching Hospitals NHS Foundation TrustD33 Royal Hallamshire HospitalGlossop RoadSheffieldS10 2JF Hosted by Sheffield Teaching Hospitals NHS Foundation Trust in partnership with 11 Trusts and Universities nationwide 1 - 9 Innovators register interest by completing a brief, 6 item Collaboration Request Form through the HRC's website portal, providing company information and support request information. Requests are reviewed by the HRC team each Monday, and if relevant and within the remit of the HRC, they will work with their national expert networks as part of a validation of need process and will then liaise with the innovator on next steps. This information is used to develop the project if they decide to work with the innovator. If they decide against working with an innovator, they provide all the gathered information and do a warm handover to another more suitable service. CognoSpeak
|
|
|
|
|
|
|
|
Mental health (MindTech)
The HRC in Mental health (MindTech) is a national centre focusing on the development, adoption and evaluation of new technologies for mental healthcare and dementia. Technology innovation in this area includes diagnosis, monitoring, treatment and support.
The team boasts extensive clinical and research expertise, alongside public involvement groups who bring invaluable lived experience to all their work.
The HRC in Mental health (MindTech) is a national centre focusing on the development, adoption and evaluation of new technologies for mental healthcare and dementia. Technology innovation in this area includes diagnosis, monitoring, treatment and support.
The team boasts extensive clinical and research expertise, alongside public involvement groups who bring invaluable lived experience to all their work. Mental health (MindTech) Mental health is a broad term that includes problems with cognition (thought processing), emotions, and behaviours. MindTech covers mental health conditions across the lifespan. Their Children and Young People’s theme focuses on mental health challenges such as anxiety, depression, self-harm and suicide as well as neurodevelopmental disorders such as ADHD, Tourette Syndrome and Autism. Their Adult theme looks at mood disorders and severe mental health conditions such as psychosis. They also have a theme focused on old age and dementia.
Feedback and advice: one-off guidance and meetings with innovators at different stages of their development journey.
Access to our networks: connect innovators to specialist networks of academics and clinicians across the UK, as well as NHS providers, NICE, and the MHRA.
Research collaborations: partner with companies on research that meets shared interests, building towards clinical evaluations and real-world evaluations to deliver evidence to support adoption and regulatory approval processes.
Events: regular events to bring together innovators, academics, clinicians, people with lived experience of mental health conditions, and other stakeholders.
Patient and Public Involvement and Engagement (PPIE): embed PPIE into all stages of research and apply co-production principle to technology development. Currently developing a PPIE support offer for innovators.
Training and resources: a knowledge base of resources and training materials which will soon be available.
Clinical themes
Children and Young People’s Mental Health
Adult Mental health and Wellbeing
Older People and Dementia
Methodological themes
Co-design and Responsible Research and Innovation
Evidence Generation & Digital Trials
Health Economics and Value Propositions
Implementation and Adoption
Expertise
Neurodevelopmental conditions (e.g., Tourette's, ADHD) within Children and Young People
Adult mood disorders (e.g., bipolar, major depressive disorder)
Public and Patient Involvement and Engagement (PPIE) methodology
Assets
Mental Health Mission
HRC MindTech HRC MindTech LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Mental Health (MindTech)Institute of Mental HealthUniversity of NottinghamJubilee CampusTriumph RoadNottinghamNG7 2TU Hosted by Nottinghamshire Healthcare NHS Foundation Trust and the University of Nottingham 3 - 9 To access support from this HRC, please contact the Industry Engagement Manager (Jake) at This email address is being protected from spambots. You need JavaScript enabled to view it. to begin discussing your innovation and your support needs. An initial call will determine that the innovator approach aligns with the HRC interests and capacity, and if they do, subsequent steps will be taken to engage other investigators and expertise onto the project.
|
|
|
|
|
|
|
Paediatrics and child health
The HRC in Paediatrics and child health transforms healthcare for children and families by accelerating the development of healthcare technologies. They unite experts in industry, healthcare, and academia in a national child health network, and support the next generation of child health technology innovators through their bespoke education programme. The voices of young people and families are integrated within each research theme through meaningful co-production.
The HRC in Paediatrics and child health transforms healthcare for children and families by accelerating the development of healthcare technologies. They unite experts in industry, healthcare, and academia in a national child health network, and support the next generation of child health technology innovators through their bespoke education programme. The voices of young people and families are integrated within each research theme through meaningful co-production. Paediatrics and child health Children and young people make up approximately 25% of the population, but are often underrepresented in research and healthtech innovations. However, this HRC focuses entirely on this population, from birth (including pre-term and birth-related brain injury) through to the transition from childhood to adulthood. They also support innovators to develop products for childhood long-term conditions and rare diseases.
Input and advice from expert clinicians and industry partners.
Involving young people and families.
Identifying and securing the right funding.
Access to the NHS and NIHR infrastructure.
Establishing partnerships and collaborations through our extensive networks across healthcare, industry, and academia.
Educational resources through our Knowledge Centre.
Evaluation and testing of health technologies through clinical trials.
Navigating the regulatory landscape and intellectual property.
Support with project management and guiding your innovation journey.
Clinical themes
Early life
Long-term conditions
Transition
Methodological themes
Mind-body integration
Child Health AI Network
Expertise
Patient and public involvement and engagement (PPIE) with children and young people and their families and carers
Education knowledge centres
Clinical insights in paediatrics (primary, secondary, tertiary)
Assets
National Centre for Child Health Technology
HRC Paediatrics HRC Paediatrics LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Paediatrics and child healthSheffield Children's NHS Foundation Trust Western BankSheffieldSouth YorkshireS10 2TN Hosted by Sheffield Children’s NHS Foundation Trust 3 - 6 Innovators wishing to access support from Paediatrics and child health should complete the Collaboration Request Form on the HRC website. Following an internal review of this form, the HRC will advise if they can provide support.
|
|
|
|
|
Rehabilitation
The HRC in Rehabilitation brings together researchers, companies, charities, patients and the public to develop technology which helps patients rehabilitate after life changing injury, trauma and illness. The team aims to help patients undergoing rehabilitation recover faster and more fully through the use of technology, supporting NHS staff with better rehabilitation equipment and techniques, and boosting the UK’s rehabilitation technology businesses. The innovation funnel feeds technologies into RehabHRC, taking ideas from technology push and clinical pull, identifying and capturing the most promising technologies for potential RehabHRC support.
The HRC in Rehabilitation brings together researchers, companies, charities, patients and the public to develop technology which helps patients rehabilitate after life changing injury, trauma and illness. The team aims to help patients undergoing rehabilitation recover faster and more fully through the use of technology, supporting NHS staff with better rehabilitation equipment and techniques, and boosting the UKâs rehabilitation technology businesses. The innovation funnel feeds technologies into RehabHRC, taking ideas from technology push and clinical pull, identifying and capturing the most promising technologies for potential RehabHRC support. Rehabilitation Rehabilitation is the process of supporting patients to recover from serious injuries, trauma and illness, to maximise their functionality, reduce disability, and overcome limitations to normal daily functioning. Modern medicine helps more people survive increasingly traumatic medical events, which means that more people need rehabilitation to help them to get back to work and other activities more quickly so that they, and their families, will have a better life and contribute to society and to the economy.
Innovation funnel theme: we can offer seed funding to innovators through funding calls associated with HRC themes.
Starting point: the best ideas often come from the people who need solutions the most - we understand the problems real people experience when it comes to rehabilitation. But it can be a long way from that initial thought to an innovation that everyone uses. Every innovation is unique, and we can provide you with support and advice throughout the process.
Supporting you: running events, courses and activities. we bring together different people with different experiences, including the people who have been there and done it before. We can offer you support and advice to clarify your concept, perfect your prototype, simplify your supply chain, meet your market, and reach the regulations that all healthcare technology has to meet.
No guarantees: launching any new product is a lot of hard work with no guarantee of success, and sometimes the best result is discovering the flaw in an idea before you waste too much time and money.
Next steps: we can help you to get initial research funding, produce your first prototype, develop a business plan, help with scaling up. We also know when others might be better suited to help you. Every product is different.
Clinical themes
Childhood
Working age
Older people
Methodological themes
Enabling participation
Supporting rehabilitation
Evaluating performance
Expertise
Assets
Seed funding provided through the Application Rounds for Innovation
National Rehabilitation Centre
HRC Rehab HRC Rehab LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in RehabilitationD Floor, West BlockQueen’s Medical CentreNottingham University Hospitals NHS TrustDerby RoadNottinghamNG7 2UH Hosted by Nottingham University Hospitals NHS Trust in partnership with Nottingham University 1 - 9 Innovators wishing to access support from HRC Rehabilitation should complete the Initial Enquiries Form on their website. Once received, the HRC will meet briefly with the innovator to gather more details and ascertain if they should apply through their formal application rounds which are theme based. The HRC runs one-on-one advice to strengthen applications. Innovators will be directed to the appropriate application call by the HRC. If innovations are not suitable, the HRC can provide guidance on grant writing, networking and signposting to other services.
|
|
|
|
|
|
Sustainable innovation
The HRC in Sustainable innovation unites researchers, clinicians and medical technology companies to develop, test, and improve medical devices, diagnostics and digital technologies, developing sustainable, innovative, and patient-focused health technologies that will benefit all.
Technological innovations have the potential to revolutionise healthcare services for everyone, helping people to better monitor their health, diagnose ill health sooner and improve management of conditions. In turn this can help to benefit our healthcare systems and the people who work in them. By working collaboratively with businesses we are developing sustainable, innovative, and patient-focused health technologies that improve patient care and benefit the NHS.
The HRC in Sustainable innovation unites researchers, clinicians and medical technology companies to develop, test, and improve medical devices, diagnostics and digital technologies, developing sustainable, innovative, and patient-focused health technologies that will benefit all.
Technological innovations have the potential to revolutionise healthcare services for everyone, helping people to better monitor their health, diagnose ill health sooner and improve management of conditions. In turn this can help to benefit our healthcare systems and the people who work in them. By working collaboratively with businesses we are developing sustainable, innovative, and patient-focused health technologies that improve patient care and benefit the NHS. Sustainable innovation A key focus in sustainable innovation, is developing products and solutions that reduce negative environmental impact and waste (e.g, single use plastics), creating circular economies (e.g., reusing, recycling and reducing medical equipment), reduce negative environmental impact (e.g. lowering clinical carbon emissions), as well as reducing the overall cost to the NHS making the delivery of services and products more financially sustainable.
Healthcare technical solutions: co-develop and evaluate data algorithms, AI, Apps and sensor technology (on person and in environments) for use in clinical and community settings.
Infrastructure & facilities: systems and partnerships are in place to quickly evaluate new technologies including; the NIHR Exeter Biomedical Research Centre, the NIHR Applied Research Collaboration South West Peninsula (PenARC), the Clinical Research Network South West Peninsula, the NIHR Exeter Clinical Research Facility, the VSimulators, University of Exeter multi-disciplinary research facility, and the Mireille Gillings Neuroimaging Centre.
Collaboration and partnerships: working with local, national and international companies as well as regulatory bodies, NHS health and care organisations, charities and development partners.
Navigating the regulatory landscape: using combined expertise to support the journey through regulation, reducing the time to target, collect and present evidence. This ensures that new developments progress through the developmental and regulatory processes in a seamless and streamlined way, reducing time to market.
Clinical themes
Rehabilitation, frailty & ementia
Diagnostics and biomarkers
Methodological themes
Digital innovation and artificial intelligence
Sustainable innovation
Commercialisation and capacity building
Expertise
Real-world evaluation
Health economics methodology
Human factors engineering
Digital, data and AI
Patient and public involvement and engagement (PPIE)
Assets
Secure access to the Southwest Secure Data Environment (SDE)
HRC Sustainable HRC Sustainable LinkedIn This email address is being protected from spambots. You need JavaScript enabled to view it. NIHR HRC in Sustainable innovationNoy Scott HouseRoyal Devon and Exeter HospitalBarrack RoadExeter EX2 5DW Hosted by Royal Devon University Healthcare NHS Foundation Trust in partnership with the University of Exeter 4 - 7 Innovators wishing to access support from Sustainable innovation should complete the Early Engagement Form on the HRC website. This form will be scored and successful innovators will be contacted to have an initiation meeting to discuss support requirements. CanSense
|
|
|
|
|